Search research articles
Contact Us
Filters
Showing results (331-340 of 380) with videos related to
Page
of 38
Sort By:
NPJ Digital Medicine
|
November 26, 2025
Artificial intelligence-enabled analysis of handheld single-lead electrocardiograms to predict incident atrial fibrillation: an analysis of the VITAL-AF randomized trial
Shaan Khurshid, Sam F Friedman, Mostafa A Al-Alusi, et al.
Gynecologic Oncology
|
November 3, 2020
A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancers
Maria M Rubinstein, Rachel N Grisham, Karen Cadoo, et al.
Molecular Oncology
|
May 28, 2025
Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab
Charles Swanton, Russell W Madison, Candice Francheska B Tambaoan, et al.
Transfusion
|
June 1, 2019
Critical developments of 2018: A review of the literature from selected topics in transfusion. A committee report from the AABB's Clinical Transfusion Medicine Committee
Claudia S Cohn, Elizabeth S Allen, Melissa M Cushing, et al.
The Lancet. Global Health
|
May 24, 2025
Safety and efficacy of praziquantel 40 mg/kg versus 80 mg/kg in preschool-aged children with intestinal schistosomiasis in Uganda: a 2 × 2 factorial, double-blind, placebo-controlled, phase 2 randomised trial
Amaya L Bustinduy, Andrew Edielu, Gloria K Ayebazibwe, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 29, 2025
Basket study of oral progesterone antagonist onapristone extended-release in combination with anastrozole in progesterone receptor-positive recurrent adult-type granulosa cell tumor of the ovary
Lindsey Finch, Sarah Andres, Alexia Iasonos, et al.
Journal for Immunotherapy of Cancer
|
January 25, 2022
Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: clinical outcomes and translational biomarker analyses
Claire F Friedman, Christine Spencer, Christopher R Cabanski, et al.
Gynecologic Oncology
|
November 25, 2018
Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade
Julia L Boland, Qin Zhou, Madhuri Martin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 14, 2025
Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case series
Tiffany Y Sia, Vivian Wan, Michael Finlan, et al.
The Lancet. Oncology
|
August 2, 2021
Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study
Milind Javle, Mitesh J Borad, Nilofer S Azad, et al.
Page
of 38
Search research articles
Search
Showing results (331-340 of 380) with videos related to
Sort By:
Page
of 38
NPJ Digital Medicine
|
November 26, 2025
Artificial intelligence-enabled analysis of handheld single-lead electrocardiograms to predict incident atrial fibrillation: an analysis of the VITAL-AF randomized trial
Shaan Khurshid, Sam F Friedman, Mostafa A Al-Alusi, et al.
Gynecologic Oncology
|
November 3, 2020
A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancers
Maria M Rubinstein, Rachel N Grisham, Karen Cadoo, et al.
Molecular Oncology
|
May 28, 2025
Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab
Charles Swanton, Russell W Madison, Candice Francheska B Tambaoan, et al.
Transfusion
|
June 1, 2019
Critical developments of 2018: A review of the literature from selected topics in transfusion. A committee report from the AABB's Clinical Transfusion Medicine Committee
Claudia S Cohn, Elizabeth S Allen, Melissa M Cushing, et al.
The Lancet. Global Health
|
May 24, 2025
Safety and efficacy of praziquantel 40 mg/kg versus 80 mg/kg in preschool-aged children with intestinal schistosomiasis in Uganda: a 2 × 2 factorial, double-blind, placebo-controlled, phase 2 randomised trial
Amaya L Bustinduy, Andrew Edielu, Gloria K Ayebazibwe, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 29, 2025
Basket study of oral progesterone antagonist onapristone extended-release in combination with anastrozole in progesterone receptor-positive recurrent adult-type granulosa cell tumor of the ovary
Lindsey Finch, Sarah Andres, Alexia Iasonos, et al.
Journal for Immunotherapy of Cancer
|
January 25, 2022
Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: clinical outcomes and translational biomarker analyses
Claire F Friedman, Christine Spencer, Christopher R Cabanski, et al.
Gynecologic Oncology
|
November 25, 2018
Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade
Julia L Boland, Qin Zhou, Madhuri Martin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 14, 2025
Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case series
Tiffany Y Sia, Vivian Wan, Michael Finlan, et al.
The Lancet. Oncology
|
August 2, 2021
Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study
Milind Javle, Mitesh J Borad, Nilofer S Azad, et al.
Page
of 38